Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis

Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis

Context: Pulmonary fibrosis is a devastating disease without effective treatment. Rosemary is appreciated since ancient times for its medicinal properties, while biomolecules originated from the plant have an antioxidant and antifibrotic effect. Objective: The effects of Rosmarinus officinalis L. (L...

Full description

Bibliographic Details
Main Authors:	Sana Bahri, Ridha Ben Ali, Khaoula Gasmi, Mona Mlika, Saloua Fazaa, Riadh Ksouri, Raja Serairi, Saloua Jameleddine, Vadim Shlyonsky
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-01-01
Series:	Pharmaceutical Biology
Subjects:	polyphenols high-performance liquid chromatography antioxidant antifibrotic
Online Access:	http://dx.doi.org/10.1080/13880209.2016.1247881

Similar Items

Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts.
by: Sana Bahri, et al.
Published: (2017-01-01)

Leaf Extract Alleviates Fibrosis Progression and Oxidative Stress Induced by Bleomycin on a Murine Model of Lung Fibrosis
by: Sana Bahri, et al.
Published: (2023-09-01)

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
by: Yuzo Suzuki, et al.
Published: (2021-07-01)

Vinpocetine’s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis
by: Mohamed Balaha, et al.
Published: (2023-01-01)

Reversal of liver fibrosis
by: Ismail Mona, et al.
Published: (2009-01-01)

Application of Pirfenidone anti-fibrosis in ophthalmology
by: Xiao Yang, et al.
Published: (2013-08-01)

Antidiabetic, antihyperlipidemic and antioxidant influences of the spice cinnamon ( Cinnamomum zeylanicumon ) in experimental rats
by: Raja Serairi Beji, et al.
Published: (2018-07-01)

Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis
by: Christina Hesse, et al.
Published: (2022-08-01)

Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
by: Benjamin Seeliger, et al.
Published: (2022-08-01)

Plasma extracellular vesicle microRNAs reflecting the therapeutic effect of the CBP/β-catenin inhibitor PRI-724 in patients with liver cirrhosis
by: Mayu Yoshida, et al.
Published: (2024-03-01)

Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways
by: Zhen Liu, et al.
Published: (2023-07-01)

The Synthesis and Biological Applications of the 1,2,3-Dithiazole Scaffold
by: Andreas S. Kalogirou, et al.
Published: (2023-04-01)

Reactivation of tuberculosis in patient treated with the antifibrotic drug nintedanib
by: Iliya Iliev Krachunov, et al.
Published: (2022-01-01)

Effects of long term sildenaﬁl on the acute phase of Peyronie’s disease in a combination treatment
by: Murat Topcuoglu, et al.
Published: (2022-09-01)

Design, Synthesis and Antifibrotic Activities of Carbohydrate- Modified 1-(Substituted aryl)-5-trifluoromethyl-2(1H) Pyridones
by: Lijian Tao, et al.
Published: (2012-01-01)

Simultaneous use of amniotic membrane and Mitomycin C in trabeculectomy for primary glaucoma
by: Usha Yadava, et al.
Published: (2017-01-01)

Post-COVID-19 pulmonary fibrosis: A case series and review of literature
by: Deependra K Rai, et al.
Published: (2021-01-01)

Effect of lesimarin against thioacetamide-induced liver cirrhosis in rat
by: Sang-Ho Ra, et al.
Published: (2019-12-01)

Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
by: Soroush Seifirad, et al.
Published: (2021-01-01)

The Ameliorative Effects of Allopurinol on Paraquat-Induced Pulmonary Fibrosis in Rats
by: Saeedeh Shariati, et al.
Published: (2019-03-01)

Antifibrotic effect of pyrimidine derivatives of Xymedon and its conjugate with L-ascorbic acid
by: G. P. Belyaev, et al.
Published: (2023-12-01)

Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
by: Vito D’Agnano, et al.
Published: (2024-02-01)

The Role of Nintedanib in the Treatment of Progressive Pulmonary Fibrosis of Autoimmune-Related Interstitial Lung Disease
by: Aulia Rahman Ardan, et al.
Published: (2023-11-01)

Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers
by: Aurelio Perez-Favila, et al.
Published: (2024-01-01)

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
by: Nuria Mendoza, et al.
Published: (2023-09-01)

Corneal Wound Healing in the Presence of Antifibrotic Antibody Targeting Collagen Fibrillogenesis: A Pilot Study
by: Zeba A. Syed, et al.
Published: (2023-08-01)

Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment
by: Yuji Iwanami, et al.
Published: (2022-09-01)

Effect of pirfenidone on tendon healing
by: Yasemin Aydinli, et al.
Published: (2023-01-01)

Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents
by: İrfan Çapan, et al.
Published: (2023-06-01)

Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio
by: S. N. Avdeev, et al.
Published: (2018-10-01)

Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease
by: Claudia-Mariana Handra, et al.
Published: (2023-05-01)

An Atypical Case of Idiopathic Pulmonary Fibrosis in a Patient from Africa
by: Ida Pesonen, et al.
Published: (2019-03-01)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
by: Gabriela Leuschner, et al.
Published: (2020-11-01)

Does Eryngium maritimum seeds extract protect against CCl4 and cisplatin induced toxicity in rats: Preliminary phytochemical screening and assessment of its in vitro and in vivo antioxidant activity and antifibrotic effect
by: Houda Mejri, et al.
Published: (2017-10-01)

Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
by: Manon Belhassen, et al.
Published: (2021-05-01)

Synthesis and Biological Evaluation of Novel Thiazolyl-Coumarin Derivatives as Potent Histone Deacetylase Inhibitors with Antifibrotic Activity
by: Viviana Pardo-Jiménez, et al.
Published: (2019-02-01)

Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
by: Yangjin Jegal, et al.
Published: (2022-04-01)

Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis
by: Ashour AA, et al.
Published: (2021-12-01)

Bisphenol A and human chronic diseases: Current evidences, possible mechanisms, and future perspectives
by: Raja Rezg, et al.
Published: (2014-03-01)

Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery
by: Michelle T. Sun, MBBS, PhD, et al.
Published: (2024-05-01)